| 1 |
Yamada R, Sakuno T, Inoue H, et al. A case of duodenal malignant lymphoma presenting as acute pancreatitis: systemic lupus erythematosus and immunosuppressive therapy as risk factors [J]. Clin J Gastroenterol, 2018, 11(4): 286-290.
|
| 2 |
Kim SJ, Jung HA, Chuang SS, et al. Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma study group [J]. J Hematol Oncol, 2013, 6(1): 86-88.
|
| 3 |
Fujishima F, Katsushima H, Fukuhara N, et al. Incidence rate, subtype frequency, and occurrence site of malignant lymphoma in the gastrointestinal tract: population-based analysis in Miyagi, Japan [J]. Tohoku J Exp Med, 2018, 245(3): 159-165.
|
| 4 |
Murase Y, Maeda N, Katano H, et al. Fulminant adenovirus hepatitis with adenovirus-associated esophagitis complicating malignant lymphoma [J]. Pathol Int, 2018, 68(4): 259-261.
|
| 5 |
Kurihara K, Fukui A, Kumano S. Malignant lymphoma of the esophagus associated with macroglobulinemia: report of a case [J]. Pathol Int, 1994, 44(9): 712-715.
|
| 6 |
Dawson IM, Cornes JS, Morson BC. Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis [J]. Br J Surg, 1961, 49: 80-89.
|
| 7 |
Olszewski AJ, Desai A. Radiation therapy administration and survival in stage I/II extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [J]. Int J Radiat Oncol Biol Phys, 2014, 88(3):642-649.
|
| 8 |
Heyman B, Yang Y. New developments in immunotherapy for lymphoma [J]. Cancer Biology & Medicine, 2018, 15(3): 7-27.
|
| 9 |
Krause SW, Gerken M, Andreesen R, et al. Treatment of B cell lymphoma with chemotherapy plus rituximab: a survival benefit can be demonstrated in the routine data of a regional cancer registry [J]. Ann Hematol, 2012, 91(4):561-570.
|
| 10 |
Bardisi ES, Alghanmi N, Merdad AA. Primary mucosa-associated lymphoid tissue lymphoma of the esophagus masquerading as a benign tumor [J]. Ann Med Surg (Lond), 2014, 3(2): 39-42.
|
| 11 |
Zinzani PL, Rigacci L, Cox M C, et al. The efficacy of lenalidomide combination therapy in heavily pretreated non-Hodgkin lymphoma patients: an Italian observational, multicenter, retrospective study [J]. Leuk Lymphoma, 2017, 58(1): 226-229.
|
| 12 |
Madabhavi I, Patel A, Revannasiddaiah S, et al. Primary esophageal burkitt′s lymphoma: a rare case report and review of literature [J]. Gastroenterol Hepatol Bed Bench, 2014, 7(4): 230-237.
|